参考文献/References:
[1]陈桃,王天,蔡琪,许家健.重组人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白治疗类风湿关节炎疗效及对血清MK和Th17/Terg的影响[J].河北医药,2019,41(9):1352-1355. [2]中华医学会风湿病学分会.强直性脊柱炎诊断及治疗指南[J].中华风湿病学杂志,2010(8):557-559. [3]艾星,张杰,王朝云,等.阿达木单抗注射液生物类似药临床试验设计考虑要点[J].中国临床药理学杂志,2019,35(23):3167-3171. [4]路峰.ASDAS、RAPID3及BASDAI病情活动性指标判断强直性脊柱炎患者活动度效果比较研究[J].中国实用医药,2017,12(32):68-69. [5]陈俊岚,周时高.强直性脊柱炎相关细胞因子的研究进展[J].江西中医药,2019,50(439):64-68. [6]蔡慧颜,钟华.强直性脊柱炎患者外周血TNF-α、IL-17、IL-23的表达[J].现代诊断与治疗,2016,27(18):3340-3342. [7]谢建丽,陈海英,王俊祥,等.超声评价抗肿瘤坏死因子α制剂对强直性脊柱炎跟腱附着点炎的疗效[J].临床荟萃,2018(5):431-433,439. [8]王星,张莹,郑军,等.TNF-α拮抗剂治疗早期强直性脊柱炎临床效果观察[J].西南国防医药,2019(12):1200-1203. [9]高丽红,刘欣,吴歆,等.Wnt/β-catenin信号通路在强直性脊柱炎成骨中的研究进展[J].第二军医大学学报,2019,40(4):435-439. [10]Feng W,Guo J,Li M.RANKL-independent modulation of osteoclastogenesis[J].J Oral Biosci,2019,61(1):16-21. [11]Davis JC Jr,van der Heijde DM,Braun J,et al.Efficacy and safety of up to 192 weeks of etanercept therapy in patients with ankylosing spondylitis[J].Ann Rheum Dis,2008,67(3):346-352. [12]Verhoef LM,van den Bemt BJ,van der Maas A,et al.Down-titration and discontinuation strategies of tumour necrosis factor-blocking agents for rheumatoid arthritis in patients with low disease activity[J].Cochrane Database Syst Rev,2019,5(5):CD010455. [13]Arends S,van der Veer E,Kamps FB,et al.Patient-tailored dose reduction of TNF-α blocking agents in ankylosing spondylitis patients with stable low disease activity in daily clinical practice[J].Clin Exp Rheumatol,2015,33(2):174-180. [14]余海燕.注射用重组人Ⅱ型肿瘤坏死因子受体抗体融合蛋白剂量递减方案与标准剂量维持方案治疗强直性脊柱炎的疗效比较[J].广州医药,2019,50(1):12-15. [15]杨娉婷,赵丽娟,肖卫国.强直性脊柱炎患者益赛普减量经验——为期1年的开放式前瞻性临床研究结果[J].中国医科大学学报,2011,40(1):57-59,63. [16]宋颖钰,崔阳,张晓,等.肿瘤坏死因子抑制剂减量维持治疗脊柱关节炎患者关节病变的初步研究[J].中华风湿病学杂志,2017,21(11):724-731. [17]王苏丽,刘维超,宋洋,等.注射用重组人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白剂量递减方案治疗强直性脊柱炎的临床疗效观察[J].中华风湿病学杂志,2016,20(11):746-749.
相似文献/References:
[1]朱晓波,常 泰.强直性脊柱炎髋关节受累磁共振横断面扫描与
冠状面扫描的对比分析[J].医学信息,2018,31(16):186.[doi:10.3969/j.issn.1006-1959.2018.16.060]
ZHU Xiao-bo,CHANG Tai.Comparative Analysis of Magnetic Resonance Cross-sectional Scan and Coronal Scan in Hip Joint of Ankylosing Spondylitis[J].Medical Information,2018,31(02):186.[doi:10.3969/j.issn.1006-1959.2018.16.060]
[2]张 伟.艾拉莫德联合塞来昔布治疗强直性脊柱炎的疗效[J].医学信息,2022,35(15):114.[doi:10.3969/j.issn.1006-1959.2022.15.026]
ZHANG Wei.Efficacy of Iguratimod Combined with Celecoxib in the Treatment of Ankylosing Spondylitis[J].Medical Information,2022,35(02):114.[doi:10.3969/j.issn.1006-1959.2022.15.026]
[3]刘军莲,戴 娜,杨 迎,等.全脊柱MRI对强直性脊柱炎急性炎症的诊断价值[J].医学信息,2019,32(16):167.[doi:10.3969/j.issn.1006-1959.2019.16.057]
LIU Jun-lian,DAI Na,YANG Ying,et al.Diagnostic Value of Total Spine MRI in Acute Inflammation of Ankylosing Spondylitis[J].Medical Information,2019,32(02):167.[doi:10.3969/j.issn.1006-1959.2019.16.057]
[4]翁於欢,王璐颖,郑 勇,等.强直性脊柱炎中医证候分布研究[J].医学信息,2020,33(01):151.[doi:10.3969/j.issn.1006-1959.2020.01.049]
WENG Yu-huan,WANG Lu-ying,ZHENG Yong,et al.Study on TCM Syndrome Distribution of Ankylosing Spondylitis[J].Medical Information,2020,33(02):151.[doi:10.3969/j.issn.1006-1959.2020.01.049]
[5]陈王曼琍,施春香.Orem自理理论护理对中西医结合治疗强直性脊柱炎的疗效研究[J].医学信息,2020,33(11):182.[doi:10.3969/j.issn.1006-1959.2020.11.060]
CHEN Man-li,SHI Chun-xiang.Study on the Curative Effect of Orem Self-care Theory Nursing Treatment of Ankylosing Spondylitis with Integrated Traditional Chinese and Western Medicine[J].Medical Information,2020,33(02):182.[doi:10.3969/j.issn.1006-1959.2020.11.060]
[6]薛三宝.MRI诊断强直性脊柱炎骶髂关节病变的影像学价值[J].医学信息,2022,35(22):142.[doi:10.3969/j.issn.1006-1959.2022.22.034]
XUE San-bao.Imaging Value of MRI in Diagnosis of Sacroiliac Joint Lesions in Ankylosing Spondylitis[J].Medical Information,2022,35(02):142.[doi:10.3969/j.issn.1006-1959.2022.22.034]